Table 2. Cost Avoidance Values by Type of Intervention.
| Intervention categories (matched study) | Value | Cost avoidancea (annualized) | Cost of pharmacist/time investeda (annualized) | Net benefita (annualized) |
|---|---|---|---|---|
| Treatment plan management (Calloway et al., 2013) | $3.75/min | $166,035.00 | $51,360.16 | $114,674.84 |
| Patient education (Randolph et al., 2018; Schumock et al., 2003) | 5.73 benefit-cost | $252,414.40 | $44,052.16 | $208,362.24 |
| Pharmacy administration (Calloway et al., 2013) | $3.75/min | $73,237.50 | $22,654.80 | $50,582.70 |
| Oral chemotherapy management (Calloway et al., 2013) | $3.75/min | $69,435.00 | $21,478.56 | $47,956.44 |
| Medication regimen/dosing change (Calloway et al., 2013) | $5/min | $65,980.00 | $15,307.36 | $50,672.64 |
| Symptom management (Lee et al., 2002) | $536/intervention | $313,024.00 | $15,199.19 | $297,824.81 |
| Drug information (Randolph et al., 2018; Schumock et al., 2003) | 11.89 benefit-cost | $111,512.94 | $9,379.76 | $102,133.18 |
| Initiate drug (Lee et al., 2002) | $536/intervention | $191,888.00 | $9,317.90 | $182,570.10 |
| ADE/Drug-drug interaction (Lee et al., 2002) | $317/intervention | $107,780.00 | $8,848.52 | $98,931.48 |
Note. ADE = adverse drug event.
a
All annualized values are estimated.